Breast Matters - In the News
Issue No. 4
In the News
Baltimore’s Best Medical Oncologists are at Johns Hopkins
John Fetting, M.D., was highlighted in Baltimore Magazine’s 2013 list of “Top Doctors in Baltimore” for his experience, dedication and expertise.
The Johns Hopkins Breast Center Welcomes New Leadership
The Department of Surgery is pleased to announce that David Euhus, M.D., professor of surgery, has been named chief of breast surgery within the Division of Surgical Oncology. In this role, he will supervise and coordinate the ongoing development and growth of breast cancer care within our Johns Hopkins Breast Centers and throughout Johns Hopkins Medicine.
Learn more about David Euhus, M.D., in our next edition of Breast Matters.
Acupuncture, Real or Sham, Eases Hot Flashes Due to Breast Cancer Chemo
Investigators at the University of Maryland Greenebaum Cancer Center and the Johns Hopkins Kimmel Cancer Center set out to see if acupuncture could reduce the severity of side effects linked to aromatase inhibitors (AIS), drugs used to treat breast cancer or prevent it from recurring after surgery. Because AIs block estrogen synthesis in postmenopausal patients, they can cause moderate to severe hot flashes, similar to those experienced during menopause. Studies indicate that up to 60 percent of women with early-stage breast cancer who receive AIs experience hot flashes, says Vered Stearns, M.D., senior study author and co-director of the Breast Cancer Program at the Johns Hopkins Kimmel Cancer Center. As has been seen in previous acupuncture studies, both real and sham weekly acupuncture treatments eased hot flashes and other side effects. Study results, published online Dec. 23 in the journal Cancer, showed few differences in overall benefits between those receiving real and sham acupuncture, and no patients experienced significant side effects from acupuncture.
Career Development Award
Roisin Connolly, M.B.B.S., was one of nine young faculty members in the U.S. recognized with a Career Development Award by the Conquer Cancer Foundation of the American Society of Clinical Oncology. This award will support a phase II clinical trial, where Connolly will study the role of novel imaging and biomarkers to determine which women benefit from anti-HER2 agents, and who may not need chemotherapy. The award is supported by The Breast Cancer Research Foundation.
Led by Antonio Wolff, M.D., the American Society of Clinical Oncology and the College of American Pathologists released guideline updates that will improve the reliability in testing for the breast cancer marker HER2. New standards include the ability to distinguish between HER2-positive and negative results—reducing inconclusive and false positive findings, enhanced regularization of tissue handling, greater laboratory performance of HER2 testing and improved reporting of test results. There is also a call for greater collaboration between oncologists, pathologists and other health care providers. New guidelines will increase accuracy and have the potential to improve overall patient outcomes.
Nipple Tattooing after Breast Cancer Video Wins Highest Telly Award
A video on nipple tattooing after mastectomy, created by the Johns Hopkins Breast Cancer Survivorship Program with funds from Susan G. Komen Maryland, was selected from 12,000 entries and awarded the highest Telly Award. This video highlights a local tattoo artist, Vinnie Myers, who specializes in nipple tattooing after breast cancer along with patient testimonials sharing their views of why this procedure is so important to the recovery process. View Video
Hopkins Researchers Are Recognized by Susan G. Komen
In September, 16 Johns Hopkins physicians and researchers were recognized at a joint breakfast with representatives from the University of Maryland and Mercy Medical Center for their work on breast cancer funded by Susan G. Komen. Current work sponsored by Komen includes early detection, differential diagnosis, risk determination, prevention strategies, drug development, overcoming drug resistance, biomarkers, personalized medicine, survivorship and symptom management, and new technologies.